Published in Am J Gastroenterol on December 01, 1999
Comparative efficacy and overall safety of different doses of consensus interferon for treatment of chronic HCV infection: a systematic review and meta-analysis. Eur J Clin Pharmacol (2010) 0.86
Management of chronic hepatitis C treatment failures: role of consensus interferon. Biologics (2009) 0.83
Review of consensus interferon in the treatment of chronic hepatitis C. Biologics (2008) 0.81
Consensus interferon: tailored therapy and the impact of adherence. Dig Dis Sci (2011) 0.78
Effect of alpha 2b interferon on inducement of mIL-2R and treatment of HCV in PBMC from patients with chronic viral hepatitis C. World J Gastroenterol (2003) 0.75
DNA primers for amplification of mitochondrial cytochrome c oxidase subunit I from diverse metazoan invertebrates. Mol Mar Biol Biotechnol (1994) 49.81
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med (2000) 5.58
The fate of certain organic acids and amides in the rabbit: 3. Hydrolysis of amides by enzymes in vitro. Biochem J (1948) 5.12
Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. J Clin Invest (1993) 4.53
Management of hepatitis B: 2000--summary of a workshop. Gastroenterology (2001) 4.17
Breath test for altered bile-acid metabolism. Lancet (1971) 3.60
Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med (1996) 3.38
Attachment of local health authority staff to general practices. 1. A study in three county boroughs with special reference to health visiting. Nurs Times (1968) 3.21
Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med (1991) 3.02
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C. Hepatology (2001) 3.02
Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med (1992) 3.01
Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature (1982) 3.01
Social influences on the sexual behavior of youth at risk for HIV exposure. Am J Public Health (1994) 2.95
Photocontrol of Hypocotyl Elongation in De-Etiolated Cucumis sativus L. : Long Term, Fluence Rate-Dependent Responses to Blue Light. Plant Physiol (1984) 2.81
Dilution assay statistics. J Clin Microbiol (1994) 2.61
Development of a culturally, theoretically and developmentally based survey instrument for assessing risk behaviors among African-American early adolescents living in urban low-income neighborhoods. AIDS Educ Prev (1995) 2.48
Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther (1991) 2.44
Sensitivity and specificity in tests of distal ileal function: prospective comparison of bile acid and vitamin B 12 absorption in ileal resection patients. Gastroenterology (1973) 2.42
Pneumocystis carinii hepatitis in the acquired immunodeficiency syndrome (AIDS) Ann Intern Med (1989) 2.42
Determination of bilirubin UDP-glucuronyl transferase activity in needle-biopsy specimens of human liver. Clin Chim Acta (1970) 2.39
A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction. Gastroenterology (1980) 2.39
Assay of Australia antigen and antibody employing double-antibody and solid-phase radioimmunoassay techniques and comparison with the passive hemagglutination methods. J Immunol (1971) 2.35
Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology (2000) 2.34
Detection of hepatitis A viral antigen by radioimmunoassay. J Immunol (1975) 2.33
Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study. N Engl J Med (1981) 2.29
The molecular basis of sulfonylurea herbicide resistance in tobacco. EMBO J (1988) 2.28
Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood (2001) 2.26
The fate of certain organic acids and amides in the rabbit. 7. An amidase of rabbit liver. Biochem J (1949) 2.26
Patients' views on their discharge from follow up in outpatient clinics: qualitative study. BMJ (1997) 2.25
Hepatic bilirubin udp-glucuronyl transferase activity in liver disease and gilbert's syndrome. N Engl J Med (1969) 2.21
Acquired hyperoxaluria, nephrolithiasis, and intestinal disease. Description of a syndrome. N Engl J Med (1972) 2.21
Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis. Am J Gastroenterol (1999) 2.19
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg (1997) 2.16
Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis (1994) 2.15
Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study. Hepatology (2001) 2.13
Leu-8/TQ1 is the human equivalent of the Mel-14 lymph node homing receptor. Nature (1989) 2.12
Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res (1999) 2.09
Detection and surveillance of colorectal cancer. JAMA (1989) 2.07
Right hepatic lobe donation for living donor liver transplantation: impact on donor quality of life. Liver Transpl (2001) 2.06
Clinical and Parasitological Observations on Induced Malaria: (Section of Tropical Diseases and Parasitology). Proc R Soc Med (1936) 2.06
E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst (2000) 2.05
Control of cell-contact sites by cyclic AMP pulses in differentiating Dictyostelium cells. Nature (1975) 2.05
Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection. Aliment Pharmacol Ther (2006) 2.04
Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology (1999) 2.04
Infectious liver diseases in three groups of Copenhagen workers: correlation of hepatitis A infection to sewage exposure. Arch Environ Health (1981) 2.03
Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group. Gastroenterology (1993) 2.03
Isoniazid-associated hepatitis in 114 patients. Gastroenterology (1975) 2.02
Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med (1984) 2.01
Evidence for in vivo trans splicing of pre-mRNAs in tobacco chloroplasts. Cell (1987) 2.00
Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology (1992) 1.98
A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation. Infect Immun (2000) 1.94
Migration of coordinated cell clusters in mesenchymal and epithelial cancer explants in vitro. Cancer Res (1995) 1.92
On establishing reference values. Can J Comp Med (1978) 1.90
Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch Biochem Biophys (1989) 1.89
A Study of Induced Malignant Tertian Malaria. Proc R Soc Med (1932) 1.89
The efficiency of specialist outreach clinics in general practice: is further evaluation needed? J Health Serv Res Policy (1997) 1.89
Validation of a recording spectrophotometric method for measurement of membrane-associated Mg- and NaK-ATPase activity. J Lab Clin Med (1979) 1.86
Establishment of a quality assurance program for human immunodeficiency virus type 1 DNA polymerase chain reaction assays by the AIDS Clinical Trials Group. ACTG PCR Working Group, and the ACTG PCR Virology Laboratories. J Clin Microbiol (1993) 1.85
Nonparenteral transmission of viral hepatitis type B (Australia antigen-associated serum hepatitis). N Engl J Med (1971) 1.84
Lymphocytes isolated from the intestinal lamina propria of normal nonhuman primates have increased expression of genes associated with T-cell activation. Gastroenterology (1988) 1.80
Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome. Mod Pathol (1989) 1.78
Injuries resulting when small children fall out of bed. Pediatrics (1977) 1.77
Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydranize metabolites. Clin Pharmacol Ther (1975) 1.75
Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease. J Clin Endocrinol Metab (1979) 1.75
Enzymatic degradation of heme. Oxygenative cleavage requiring cytochrome P-450. Biochemistry (1972) 1.71
Biophysical and biochemical heterogeneity of purified hepatitis B antigen. J Virol (1972) 1.70
Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis. Hepatology (1985) 1.70
Review article: hepatitis vaccination in patients with chronic liver disease. Aliment Pharmacol Ther (2004) 1.68
Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation. Am J Transplant (2010) 1.67
Calmodulin binding to glutamate decarboxylase is required for regulation of glutamate and GABA metabolism and normal development in plants. EMBO J (1996) 1.66
A plant glutamate decarboxylase containing a calmodulin binding domain. Cloning, sequence, and functional analysis. J Biol Chem (1993) 1.65
Recurrence risk of stillbirth in a second pregnancy. BJOG (2010) 1.64
Liver transplantation for patients with alcoholism and end-stage liver disease. Am J Gastroenterol (1993) 1.64
Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene (2000) 1.63
Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology (1997) 1.63
Ascitic fluid analysis in malignancy-related ascites. Hepatology (1988) 1.62
Spontaneous bacterial peritonitis. Hepatology (1982) 1.61
The diagnosis of child sexual abuse. Am J Dis Child (1992) 1.59
Adult living donor liver transplantation using a right hepatic lobe. Transplantation (1998) 1.59
Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group. Hepatology (1999) 1.59
Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology (1992) 1.58
Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome. Am J Gastroenterol (2001) 1.57
Gallbladder function in the human female: effect of the ovulatory cycle, pregnancy, and contraceptive steroids. Gastroenterology (1982) 1.57
Hepatotoxicity: pathogenesis and therapeutic intervention. Clin Gastroenterol (1979) 1.57
Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology (1995) 1.56
Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: a systematic review. Liver Transpl (2001) 1.55
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology (2000) 1.55
Bleeding from a Meckel's diverticulum after the use of ibuprofen. Am J Gastroenterol (1992) 1.54
Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver. J Infect Dis (2001) 1.54
Development and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease--the LDQOL 1.0. Am J Gastroenterol (2000) 1.53
Allograft rejection after liver transplantation for autoimmune liver diseases. Liver Transpl Surg (1998) 1.53
Comparison of the 15q deletions in Prader-Willi and Angelman syndromes: specific regions, extent of deletions, parental origin, and clinical consequences. Am J Med Genet (1990) 1.53
The enigma of the gene coding for ribosomal protein S12 in the chloroplasts of Nicotiana. Nucleic Acids Res (1986) 1.52
Sexual practices and intentions among preadolescent and early adolescent low-income urban African-Americans. Pediatrics (1994) 1.52
Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers. J Clin Invest (1983) 1.52
Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest (1998) 1.52
Decreased microfilarial load and its effect on the calculation of prevalence and the rate of false negatives in the detection of onchocerciasis. Int J Epidemiol (1983) 1.50